Antibodies are like "guided missiles" that find and attack cancer cells, but cancer-causing mutations inside cells have ...

The order of cancer-driving mutations—genetic changes—plays an important role in whether tumors in the intestine can develop, new research reveals. These are the findings published on 3 December in ...

Scientists at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, and ...

One of the most commonly mutated oncogenes in cancer, KRAS mutations are seen in pancreatic cancer, colon cancer and non-small cell lung cancer, among others. Mutations of KRAS have long been targets ...

South Korean researchers have developed a new antibody capable of precisely targeting mutations in hard-to-treat cancers — ...

An AI-designed antibody has been developed that selectively targets cancer cells carrying the KRAS(G12D) mutation.

Chromosome 13q linkage promotes RB1 hemizygosity during BRCA2 LOH, lowering the ‘two-hit’ barrier and predisposing to ...

A first-in-human KRAS-targeted pancreatic cancer vaccine elicited durable immune responses in 90% of participants, and slowed ...

An international team of scientists headed by researchers at the University of Edinburgh, has created a complete map showing how hundreds of possible mutations in a key cancer gene, CTNNB1, influence ...

Still, the results provide evidence that cancer development is shaped not only by environmental damage and acquired mutations, but also by the genetic background in which those mutations occur. The ...

An experimental vaccine to prevent pancreatic cancer in people at high risk of developing the disease has shown encouraging ...